RBF Capital’s iShares Biotechnology ETF IBB Stock Holding History

RBF Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-14,000	Closed	-$2.29M	–	489
2021 Q2	$2.29M	Buy	+14,000	New	+$2.16M	0.13%	162

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

RBF Capital's IBB Position: Q3 2021 in Review

RBF Capital sold out of iShares Biotechnology ETF (IBB) in Q3 2021, closing a stake of 14,000 shares — an estimated $2.29M sold.

RBF Capital first reported a position in IBB in Q2 2021 and held it in 1 quarter. The position peaked at $2.29M in Q2 2021. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

RBF Capital reported no remaining iShares Biotechnology ETF position as of Q3 2021 after selling out during the quarter.
RBF Capital sold 14,000 iShares Biotechnology ETF shares in Q3 2021, an estimated $2.29M.
RBF Capital first reported a position in iShares Biotechnology ETF in Q2 2021 and held it in 1 quarter.
RBF Capital's iShares Biotechnology ETF position peaked at $2.29M in Q2 2021.
855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on RBF Capital's 13F filing for Q3 2021, filed 15 Nov 2021.